Vroegdiagnostiek van de ziekte van Alzheimer: de rol van Positron Emissie Tomografie (PET)

by Wiesje M. van der Flier, Rik Ossenkoppele, Bart N. M. van Berckel, Philip Scheltens
Published 2013-08-01

Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising

by Sandeep S. V. Golla, Mark Lubberink, Bart N. M. van Berckel, Adriaan A. Lammertsma, Ronald Boellaard
Published 2017-04-01

Model selection criteria for dynamic brain PET studies

by Sandeep S. V. Golla, Sofie M. Adriaanse, Maqsood Yaqub, Albert D. Windhorst, Adriaan A. Lammertsma, Bart N. M. van Berckel, Ronald Boellaard
Published 2017-12-01

Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions

by Jorge Jovicich, Frederik Barkhof, Claudio Babiloni, Karl Herholz, Christoph Mulert, Bart N.M. vanBerckel, Giovanni B. Frisoni, SRA‐NED JPND Working Group
Published 2019-12-01

Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals

by Lyduine E. Collij, Sophie E. Mastenbroek, Gemma Salvadó, Alle Meije Wink, Pieter Jelle Visser, Frederik Barkhof, Bart. N.M. vanBerckel, Isadora Lopes Alves
Published 2021-01-01

Physical activity levels in cognitively normal and cognitively impaired oldest-old and the association with dementia risk factors: a pilot study

by Marijn Muurling, Maryam Badissi, Casper de Boer, Nienke Legdeur, Frederik Barkhof, Bart N.M. van Berckel, Andrea B. Maier, Mirjam Pijnappels, Pieter Jelle Visser
Published 2023-03-01

[11C]PIB amyloid quantification: effect of reference region selection

by Fiona Heeman, Janine Hendriks, Isadora Lopes Alves, Rik Ossenkoppele, Nelleke Tolboom, Bart N. M. van Berckel, Adriaan A. Lammertsma, Maqsood Yaqub, on behalf of the AMYPAD Consortium
Published 2020-10-01

Parametric imaging of dual-time window [18F]flutemetamol and [18F]florbetaben studies

by Fiona Heeman, Maqsood Yaqub, Janine Hendriks, Ilona Bader, Frederik Barkhof, Juan Domingo Gispert, Bart N.M. van Berckel, Isadora Lopes Alves, Adriaan A. Lammertsma
Published 2021-07-01

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

by Eline A. J. Willemse, Betty M. Tijms, Bart N. M. vanBerckel, Nathalie Le Bastard, Wiesje M. van derFlier, Philip Scheltens, Charlotte E. Teunissen
Published 2021-01-01

Head-to-head comparison of relative cerebral blood flow derived from dynamic [18F]florbetapir and [18F]flortaucipir PET in subjects with subjective cognitive decline

by Hayel Tuncel, Denise Visser, Tessa Timmers, Emma E. Wolters, Rik Ossenkoppele, Wiesje M. van der Flier, Bart N. M. van Berckel, Ronald Boellaard, Sandeep S. V. Golla
Published 2023-10-01

Amyloid‐β PET and CSF in an autopsy‐confirmed cohort

by Juhan Reimand, Baayla D. C. Boon, Lyduine E. Collij, Charlotte E. Teunissen, Annemieke J. M. Rozemuller, Bart N. M. vanBerckel, Philip Scheltens, Rik Ossenkoppele, Femke Bouwman
Published 2020-11-01

Contralateral improvement of cerebrovascular reactivity and TIA frequency after unilateral revascularization surgery in moyamoya vasculopathy

by Pieter T. Deckers, Wytse van Hoek, Annick Kronenburg, Maqsood Yaqub, Jeroen C.W. Siero, Alex A. Bhogal, Bart N.M. van Berckel, Albert van der Zwan, Kees P.J. Braun
Published 2021-01-01

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

by Arno de Wilde, Juhan Reimand, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Wiesje M. van der Flier, Philip Scheltens, Bart N. M. van Berckel, Femke Bouwman, Rik Ossenkoppele
Published 2019-09-01

Added value of amyloid PET in individualized risk predictions for MCI patients

by Ingrid S. vanMaurik, Laura M. van derKall, Arno deWilde, Femke H. Bouwman, Philip Scheltens, Bart N.M. vanBerckel, Johannes Berkhof, Wiesje M. van derFlier, Alzheimer's Disease Neuroimaging Initiative
Published 2019-12-01

Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old

by Wiesje Pelkmans, Nienke Legdeur, Mara tenKate, Frederik Barkhof, Maqsood M. Yaqub, Henne Holstege, Bart N. M. vanBerckel, Philip Scheltens, Wiesje M. van derFlier, Pieter Jelle Visser, Betty M. Tijms
Published 2021-02-01

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

by Tessa Timmers, Rik Ossenkoppele, Emma E. Wolters, Sander C. J. Verfaillie, Denise Visser, Sandeep S. V. Golla, Frederik Barkhof, Philip Scheltens, Ronald Boellaard, Wiesje M. van der Flier, Bart N. M. van Berckel
Published 2019-07-01

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases

by Juhan Reimand, Arno de Wilde, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens, Bart N. M. van Berckel, Rik Ossenkoppele, Femke Bouwman
Published 2019-12-01

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status

by Rosha Babapour Mofrad, Philip Scheltens, SangYun Kim, Sungmin Kang, Young Chul Youn, Seong Soo A. An, Jori Tomassen, Bart N. M. van Berckel, Pieter Jelle Visser, Wiesje M. van der Flier, Charlotte E. Teunissen
Published 2021-07-01

Widespread disruption of functional brain organization in early-onset Alzheimer's disease.

by Sofie M Adriaanse, Maja A A Binnewijzend, Rik Ossenkoppele, Betty M Tijms, Wiesje M van der Flier, Teddy Koene, Lieke L Smits, Alle Meije Wink, Philip Scheltens, Bart N M van Berckel, Frederik Barkhof
Published 2014-01-01

A longitudinal study on quality of life along the spectrum of Alzheimer’s disease

by Arenda Mank, Judith J. M. Rijnhart, Ingrid S. van Maurik, Linus Jönsson, Ron Handels, Els D. Bakker, Charlotte E. Teunissen, Bart N. M. van Berckel, Argonde C. van Harten, Johannes Berkhof, Wiesje M. van der Flier
Published 2022-09-01